| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
22,939 |
19,494 |
$4.13M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,015 |
18,042 |
$3.73M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,695 |
5,824 |
$1.13M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,469 |
4,495 |
$829K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,607 |
4,630 |
$813K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,446 |
3,832 |
$774K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,391 |
2,140 |
$546K |
| G0378 |
Hospital observation service, per hour |
5,097 |
2,909 |
$391K |
| 59025 |
Fetal non-stress test |
1,864 |
1,410 |
$307K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,461 |
1,307 |
$259K |
| 93975 |
|
2,141 |
1,895 |
$154K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,505 |
1,359 |
$152K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
817 |
725 |
$151K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
476 |
438 |
$120K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
559 |
518 |
$101K |
| 76830 |
Ultrasound, transvaginal |
1,022 |
937 |
$89K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,287 |
796 |
$79K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,081 |
1,734 |
$75K |
| 80053 |
Comprehensive metabolic panel |
23,166 |
18,229 |
$74K |
| 70496 |
|
275 |
258 |
$72K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
742 |
662 |
$58K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,238 |
1,065 |
$57K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,076 |
2,727 |
$55K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,220 |
1,124 |
$53K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,006 |
1,696 |
$46K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
353 |
321 |
$45K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,828 |
2,330 |
$39K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
672 |
635 |
$39K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,588 |
11,053 |
$37K |
| 71045 |
Radiologic examination, chest; single view |
11,032 |
9,033 |
$35K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,490 |
11,422 |
$32K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,129 |
5,223 |
$29K |
| 71046 |
Radiologic examination, chest; 2 views |
2,662 |
2,289 |
$26K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,050 |
580 |
$25K |
| 85027 |
|
30,172 |
22,002 |
$25K |
| 93971 |
|
336 |
296 |
$24K |
| 97163 |
|
354 |
296 |
$23K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
783 |
672 |
$19K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
577 |
508 |
$19K |
| 87040 |
|
2,799 |
1,931 |
$18K |
| 84484 |
|
9,572 |
6,932 |
$15K |
| 86756 |
|
2,896 |
2,658 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,416 |
5,215 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,806 |
2,325 |
$13K |
| 83880 |
|
2,080 |
1,694 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
310 |
293 |
$11K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
108 |
99 |
$9K |
| 76857 |
|
151 |
140 |
$9K |
| 81025 |
|
1,874 |
1,670 |
$7K |
| 85379 |
|
1,793 |
1,608 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,195 |
1,915 |
$6K |
| 97116 |
|
320 |
168 |
$5K |
| 70498 |
|
284 |
262 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
684 |
589 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,430 |
1,242 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
103 |
63 |
$4K |
| 73564 |
|
460 |
349 |
$4K |
| 80076 |
|
1,195 |
938 |
$4K |
| 85610 |
|
7,061 |
5,476 |
$4K |
| 84703 |
|
6,796 |
5,795 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,502 |
1,998 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,675 |
9,309 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
310 |
293 |
$3K |
| 83690 |
|
7,774 |
6,392 |
$3K |
| 83735 |
|
5,064 |
3,841 |
$3K |
| 97162 |
|
137 |
98 |
$3K |
| 0042T |
|
12 |
12 |
$3K |
| 83605 |
|
2,339 |
1,800 |
$3K |
| 80061 |
Lipid panel |
1,085 |
936 |
$3K |
| 73030 |
|
491 |
404 |
$3K |
| 74018 |
|
378 |
346 |
$3K |
| 70486 |
|
116 |
101 |
$2K |
| 86885 |
|
2,202 |
1,817 |
$2K |
| 86900 |
|
3,588 |
3,054 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,106 |
1,536 |
$2K |
| 76642 |
|
12 |
12 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,285 |
2,723 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,842 |
6,236 |
$2K |
| 81001 |
|
7,895 |
6,606 |
$2K |
| 88304 |
|
136 |
120 |
$2K |
| A9270 |
Non-covered item or service |
5,977 |
1,255 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,054 |
467 |
$2K |
| 85730 |
|
4,426 |
3,542 |
$2K |
| 73130 |
|
325 |
268 |
$2K |
| 73630 |
|
436 |
372 |
$1K |
| 86901 |
|
2,374 |
2,014 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,823 |
7,929 |
$1K |
| 81003 |
|
5,230 |
4,554 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,660 |
5,207 |
$1K |
| 73610 |
|
328 |
292 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,356 |
5,310 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,111 |
4,684 |
$945.46 |
| 84702 |
|
1,473 |
1,248 |
$898.98 |
| 87070 |
|
2,026 |
1,713 |
$889.35 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
203 |
181 |
$879.86 |
| 82550 |
|
1,305 |
989 |
$827.50 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
15 |
15 |
$772.44 |
| 90715 |
|
38 |
37 |
$755.83 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,224 |
1,581 |
$754.95 |
| 96376 |
|
652 |
527 |
$673.43 |
| 84439 |
|
285 |
226 |
$595.28 |
| 86140 |
|
392 |
330 |
$555.63 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,844 |
2,220 |
$393.01 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
26 |
12 |
$392.76 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,973 |
2,737 |
$356.77 |
| 82565 |
|
466 |
402 |
$264.43 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
185 |
166 |
$189.78 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
1,280 |
1,129 |
$177.83 |
| 82553 |
|
75 |
26 |
$176.10 |
| 87186 |
|
709 |
599 |
$174.97 |
| 97535 |
Self-care/home management training, each 15 minutes |
13 |
13 |
$172.12 |
| 85651 |
|
152 |
136 |
$124.30 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
125 |
124 |
$105.98 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
126 |
125 |
$92.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
900 |
684 |
$86.90 |
| J2060 |
Injection, lorazepam, 2 mg |
868 |
631 |
$79.70 |
| 73590 |
|
16 |
13 |
$75.26 |
| 82150 |
|
111 |
97 |
$73.77 |
| 82607 |
|
20 |
14 |
$72.39 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
986 |
829 |
$68.31 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,372 |
1,048 |
$48.16 |
| 73560 |
|
21 |
18 |
$41.71 |
| 82248 |
|
41 |
33 |
$31.87 |
| 76376 |
|
260 |
219 |
$29.22 |
| 87077 |
|
198 |
163 |
$28.75 |
| 87147 |
|
30 |
25 |
$27.57 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
349 |
283 |
$22.75 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
199 |
169 |
$19.33 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
218 |
133 |
$15.59 |
| 85652 |
|
13 |
13 |
$13.60 |
| J1815 |
Injection, insulin, per 5 units |
211 |
103 |
$12.61 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
239 |
214 |
$11.55 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
76 |
56 |
$9.39 |
| S0028 |
Injection, famotidine, 20 mg |
259 |
244 |
$8.06 |
| 84520 |
|
17 |
12 |
$7.11 |
| 84100 |
|
46 |
37 |
$6.42 |
| J1644 |
Injection, heparin sodium, per 1000 units |
86 |
49 |
$6.05 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
313 |
180 |
$5.27 |
| 87205 |
|
16 |
12 |
$5.22 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
139 |
123 |
$4.85 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
199 |
171 |
$3.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
407 |
306 |
$2.84 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
332 |
255 |
$2.25 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
395 |
347 |
$0.50 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
25 |
24 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
474 |
401 |
$0.00 |
| J3490 |
Unclassified drugs |
425 |
297 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
30 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
27 |
24 |
$0.00 |
| C1769 |
Guide wire |
24 |
13 |
$0.00 |
| 73090 |
|
17 |
14 |
$0.00 |
| 73110 |
|
38 |
36 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
145 |
124 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
14 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
18 |
13 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
27 |
24 |
$0.00 |